The effect of 12 weeks Anethum graveolens (dill) on metabolic markers in patients with metabolic syndrome; a randomized double blind controlled trial
Open Access
- 4 October 2012
- journal article
- Published by Springer Science and Business Media LLC in DARU Journal of Pharmaceutical Sciences
- Vol. 20 (1), 47
- https://doi.org/10.1186/2008-2231-20-47
Abstract
The clustering of metabolic abnormalities defined as metabolic syndrome is now both a public health and a clinical problem .While interest in herbal medicine has greatly increased, lack of human evidence to support efficacies shown in animals does exist. This clinical trial study designed to investigate whether herbal medicine, Anethum graveolens (dill) extract, could improve metabolic components in patients with metabolic syndrome. A double-blind, randomized, placebo-controlled trial using a parallel design was conducted. 24 subjects who had metabolic syndrome diagnostic criteria (update of ATP III) were randomly assigned to either dill extract (n = 12) or placebo (n = 12) for 3 months. Across lipid component of metabolic syndrome, no significant differences in triglyceride (TG) concentration and high density lipoprotein cholesterol were seen between the two groups. However TG improved significantly from baseline (257.0 vs. 201.5p = 0.01) with dill treatment but such a significant effect was not observed in placebo group. Moreover, no significant differences in waist circumference, blood pressure and fasting blood sugar were seen between two groups after 3 months follow up period. In this small clinical trial in patients with metabolic syndrome, 12 weeks of dill extract treatment had a beneficial effect in terms of reducing TG from baseline. However dill treatment was not associated with a significant improvement in metabolic syndrome related markers compared to control group. Larger studies might be required to prove the efficacy and safety of long-term administration of dill to resolve metabolic syndrome components.Keywords
This publication has 18 references indexed in Scilit:
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Antibacterial and phytochemical screening of Anethum graveolens, Foeniculum vulgare and Trachyspermum ammiBMC Complementary and Alternative Medicine, 2009
- The effect of Anethum graveolens L. (dill) on corticosteroid induced diabetes mellitus: involvement of thyroid hormonesPhytotherapy Research, 2008
- Hypolipidemic activity of Anethum graveolens in ratsPhytotherapy Research, 2007
- Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patientsLipids in Health and Disease, 2007
- Comparison of Essential Oils from Three Plants for Enhancement of Antimicrobial Activity of Nitrofurantoin against EnterobacteriaChemotherapy, 2006
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Metabolic Syndrome and its Associated Risk Factors in Healthy Adults: APopulation-Based Study in IranMetabolic Syndrome and Related Disorders, 2006
- Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart, Lung, and Blood InstituteArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Composition, Quality Control, and Antimicrobial Activity of the Essential Oil of Long-Time Stored Dill (Anethum graveolens L.) Seeds from BulgariaJournal of Agricultural and Food Chemistry, 2003